We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+20.42%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.1B
AUM Growth
+$380M
(+14%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-34.94%
Top 10 Holdings %
Top 10 Hldgs %
37.76%
Holding
89
New
16
Increased
13
Reduced
14
Closed
12
Top Buys
| 1 |
Apogee Therapeutics
APGE
|
+$50.7M |
| 2 |
CG Oncology
CGON
|
+$46.2M |
| 3 |
Ironwood Pharmaceuticals
IRWD
|
+$42.3M |
| 4 |
Legend Biotech
LEGN
|
+$41.1M |
| 5 |
Transmedics
TMDX
|
+$40.9M |
Top Sells
| 1 |
Immunocore
IMCR
|
+$41.8M |
| 2 |
Lantheus
LNTH
|
+$30.7M |
| 3 |
DAWN
Day One Biopharmaceuticals
DAWN
|
+$30.6M |
| 4 |
Keros Therapeutics
KROS
|
+$22.6M |
| 5 |
Amgen
AMGN
|
+$16.8M |
Sector Composition
| 1 | Healthcare | 57.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Harrow
HROW
$1.6B
| $1.67M | 0.05% |
125,967
-1,372,617
| -92% | -$14.6M |
|
|
52
Amgen
AMGN
$193B
| – | – |
-58,200
| Closed | -$16.8M |
|
53
Compass Therapeutics
CMPX
$385M
| – | – |
-317,761
| Closed | -$496K |
|
54
Denali Therapeutics
DNLI
$3.65B
| – | – |
-461,769
| Closed | -$9.91M |
|
55
Dyne Therapeutics
DYN
$3.97B
| – | – |
-755,811
| Closed | -$10.1M |
|
|
HLVX
56
DELISTED
HilleVax
HLVX
| – | – |
-203,407
| Closed | -$3.26M |
|
|
57
Immunocore
IMCR
$1.76B
| – | – |
-611,365
| Closed | -$41.8M |
|
|
58
Lantheus
LNTH
$6.79B
| – | – |
-495,100
| Closed | -$30.7M |
|
|
MRUS
59
DELISTED
Merus
MRUS
| – | – |
-370,679
| Closed | -$10.2M |
|
|
RAPT
60
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-48,663
| Closed | -$9.67M |
|
|
TERN
61
DELISTED
Terns Pharmaceuticals
TERN
| – | – |
-2,318,050
| Closed | -$15M |
|
|
THRD
62
DELISTED
Third Harmonic Bio
THRD
| – | – |
-1,316,018
| Closed | -$14.4M |
|
63
Viridian Therapeutics
VRDN
$2.1B
| – | – |
-323,102
| Closed | -$7.04M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM